查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2035416

2034年全球醫藥包裝市場預測－依產品類型、材料、劑型、通路、技術、最終用戶及地區分類的分析

Pharmaceutical Packaging Market Forecasts to 2034 - Global Analysis By Product Type (Primary Packaging, Secondary Packaging, and Tertiary Packaging), Material, Dosage Form, Distribution Channel, Technology, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，預計到 2026 年，全球藥品包裝市場規模將達到 1,703 億美元，並在預測期內以 6.6% 的複合年成長率成長，到 2034 年將達到 2,839 億美元。

藥品包裝包括初級包裝、二級包裝和三級包裝，旨在保護和密封藥品，並安全地將其送達最終用戶。這些包裝包括瓶子、泡殼包裝、管瓶、預填充式注射器、紙盒和瓦楞紙箱。藥品包裝旨在確保產品完整性、延長保存期限並符合嚴格的安全法規，使製造商能夠維持藥物療效和患者安全。隨著智慧技術、防偽功能和永續材料的引入，該市場正在快速發展，從而顯著改善全球醫療保健物流並提高用藥依從性。

生物製藥和注射的需求不斷成長

糖尿病、癌症和自體免疫疾病等慢性病的日益普及推動了生物製藥和注射療法的發展。這些對溫度敏感且結構複雜的分子需要先進的包裝解決方案，例如預填充式注射器、管瓶和藥筒，以確保其無菌性和穩定性。製藥公司正在增加對阻隔性包裝的投資，以保護生物製藥免受潮氣、光照和污染的影響。自我給藥和居家醫療的興起進一步提升了對易於使用、即用型注射劑包裝的需求。隨著全球生物製藥產品線的不斷擴展，包裝創新對於維持藥物療效和提高患者依從性至關重要，加速了專用容器系統的市場成長。

原物料成本波動和供應鏈不穩定

藥品包裝嚴重依賴塑膠、玻璃、鋁和紙板，而這些材料的價格極易受到地緣政治緊張局勢、能源成本和貿易政策的影響而波動。原物料價格飆升會擠壓包裝製造商的利潤空間，迫使他們與製藥公司重新談判合約。此外，供應鏈中斷，例如全球危機期間發生的供應鏈中斷，會導致橡膠塞、瓶蓋和特殊薄膜等關鍵零件的供應延遲。中小包裝加工商難以獲得品質穩定的原料，導致生產瓶頸。這些波動為長期定價協議帶來不確定性，挑戰即時庫存模式，最終阻礙市場穩定和成長潛力。

智慧包裝技術介紹

近距離場通訊 (NFC)、無線射頻識別 (RFID) 和QR碼整合到藥品包裝中，正在徹底改變藥品安全性和患者參與度。智慧包裝能夠實現即時溫度監測、防篡改和防偽措施，同時也能讓患者取得電子版附加檔說明書和用藥提醒。監管機構日益支持強制性序列化和可追溯性，為智慧包裝的推廣應用創造了有利環境。在新興市場，認證技術正被迅速採用，作為打擊假藥的有效手段。印刷電子技術和低成本感測器的創新使得智慧包裝的成本更加親民，即使是用於非處方藥也不例外。這一趨勢正在為包裝加工商和技術供應商開闢新的收入來源。

對塑膠廢棄物制定嚴格的環境法規

世界各國政府正對一次性塑膠和不可回收包裝材料實施嚴格的監管，直接影響傳統的藥品泡殼包裝、藥瓶和塑膠薄膜。生產者延伸責任制（EPR）要求製造商管理廢棄產品的處置，從而增加了營運成本。醫療機構和藥局面臨越來越大的壓力，需要減少藥品包裝產生的塑膠廢棄物。雖然生質塑膠和可回收替代品已經存在，但它們通常缺乏對濕度敏感和無菌藥品所需的阻隔性。在不影響產品安全的前提下過渡到永續材料需要大量的研發投入和一段時間的重新認證。違反監管規定可能導致罰款和聲譽損害，從而威脅現有的包裝生產線。

新冠疫情的影響

疫情大大加速了對藥品包裝的需求，尤其是疫苗、診斷試劑和基本藥物的包裝需求。初期，封鎖措施擾亂了原料供應鏈和管瓶的生產，導致供不應求。然而，包裝製造商迅速擴大了管瓶、預填充式注射器和低溫運輸運輸容器的產量。這場危機推動了溫控三級包裝和無菌填充生產線的創新。監管機構緊急核准了替代材料和供應商的使用。疫情後，該產業優先考慮供應鏈多元化、數位化序列化和建立彈性包裝網路。為防止未來再次出現供應中斷，對自動化和近岸外包的投資也不斷增加。

在預測期內，初級包裝領域預計將佔據最大的市場佔有率。

預計在預測期內，初級包裝領域將佔據最大的市場佔有率，這主要得益於與藥品直接接觸以及嚴格的安全要求。瓶子、泡殼包裝、管瓶、安瓿、預填充式注射器和藥筒對於維持無菌性、穩定性和劑量準確性至關重要。高阻隔薄膜和兒童安全蓋等技術進步正在提升病患安全。生物製藥和注射需求的成長正在推動管瓶和預填充式注射器的需求。

預計在預測期內，智慧包裝領域將呈現最高的複合年成長率。

在預測期內，智慧包裝領域預計將呈現最高的成長率，這主要受假藥案件增多以及法規強制序列化要求的推動。 RFID、NFC 和溫度感測器的整合，能夠實現即時追蹤、防篡改，並透過數位說明書與病人參與。製藥公司正在採用互聯包裝來提高供應鏈的透明度和用藥依從性。在已開發市場和新興市場，這一領域對於確保藥品真偽和病人安全正變得日益重要。

市佔率最大的地區：

在預測期內，北美預計將佔據最大的市場佔有率，這主要得益於先進的製藥生產技術、生物製藥的高消費量以及嚴格的序列化法規。美國之所以處於主導地位，是因為擁有眾多包裝創新企業，並且對預填充式注射器和智慧包裝的需求強勁。強勁的醫療費用支出和對防偽技術的早期應用進一步鞏固了其市場主導地位。完善的供應鏈和清晰的法規環境，使得先進智慧包裝解決方案能夠在全部區域快速商業化。

複合年成長率最高的地區：

在預測期內，亞太地區預計將呈現最高的複合年成長率，這主要得益於中國、印度和東南亞藥品生產的擴張。學名藥出口增加、合約包裝業務拓展以及政府促進本地生產的舉措，都推動了市場需求的成長。醫療基礎設施的快速現代化和慢性病的盛行率上升，也促進了初級包裝的消費。成本優勢、來自全球公司的技術轉移以及序列化和智慧包裝解決方案的日益普及，都顯著加速了該地區的市場成長。

免費客製化服務：

所有購買此報告的客戶均可享受以下免費自訂選項之一：

  • 企業概況
    • 對其他市場參與者（最多 3 家公司）進行全面分析
    • 對主要公司進行SWOT分析（最多3家公司）
  • 區域分類
    • 應客戶要求，我們提供主要國家的市場估算和預測，以及複合年成長率（註：需進行可行性檢查）。
  • 競爭性標竿分析
    • 根據產品系列、地理覆蓋範圍和策略聯盟對領先公司進行基準分析。

目錄

第1章執行摘要

  • 市場概覽及主要亮點
  • 成長動力、挑戰與機遇
  • 競爭格局概述
  • 戰略洞察與建議

第2章：研究框架

  • 研究目標和範圍
  • 相關人員分析
  • 研究假設和限制
  • 調查方法

第3章 市場動態與趨勢分析

  • 市場定義與結構
  • 主要市場促進因素
  • 市場限制與挑戰
  • 投資成長機會和重點領域
  • 產業威脅與風險評估
  • 技術與創新展望
  • 新興市場/高成長市場
  • 監管和政策環境
  • 新冠疫情的影響及復甦前景

第4章：競爭環境與策略評估

  • 波特五力分析
    • 供應商的議價能力
    • 買方的議價能力
    • 替代品的威脅
    • 新進入者的威脅
    • 競爭公司之間的競爭
  • 主要公司市佔率分析
  • 產品基準評效和效能比較

第5章 全球藥品包裝市場：依產品類型分類

  • 初級包裝
    • 瓶子
    • 吸塑包裝
    • 管瓶安瓿
    • 預填充式注射器
    • 墨水匣
    • 小包裝/帶狀包裝
  • 二級包裝
    • 紙箱
    • 標籤和附加檔
    • 展示盒
  • 三級包裝
    • 瓦楞紙箱
    • 托盤收縮包裝
    • 桶子和散裝容器

第6章 全球藥品包裝市場：依材料分類

  • 塑膠聚合物
  • 玻璃
  • 紙張和紙板
  • 鋁箔
  • 生質塑膠和永續材料
  • 其他材料

第7章 全球藥品包裝市場：依劑型分類

  • 片劑和膠囊
  • 液體和糖漿
  • 注射藥物
  • 粉末/顆粒
  • 乳膏和軟膏
  • 氣霧劑
  • 經皮吸收貼劑

第8章 全球藥品包裝市場：依通路分類

  • 直銷
  • 銷售代理商和批發商
  • 電子商務數位平台

第9章 全球醫藥包裝市場：依技術分類

  • 吸塑包裝
  • 條狀包裝
  • 瓶裝灌裝和封蓋
  • 無菌包裝
  • 無菌包裝
  • 智慧包裝
  • 防偽包裝
  • 兒童安全包裝/老人包裝

第10章 全球藥品包裝市場：依最終用戶分類

  • 製藥和生物製藥製造商
  • 契約製造組織（CMO）
  • 合約包裝營運商 (CPO)
  • 零售藥局和醫院藥局
  • 臨床研究實驗室

第11章 全球藥品包裝市場：按地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 比利時
    • 瑞典
    • 瑞士
    • 波蘭
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 馬來西亞
    • 新加坡
    • 越南
    • 其他亞太國家
  • 南美洲
    • 巴西
    • 阿根廷
    • 哥倫比亞
    • 智利
    • 秘魯
    • 其他南美國家
  • 世界其他地區（RoW）
    • 中東
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 卡達
      • 以色列
      • 其他中東國家
    • 非洲
      • 南非
      • 埃及
      • 摩洛哥
      • 其他非洲國家

第12章 策略市場資訊

  • 工業價值網路和供應鏈評估
  • 空白區域和機會地圖
  • 產品演進與市場生命週期分析
  • 通路、經銷商和打入市場策略的評估

第13章 產業趨勢與策略舉措

  • 併購
  • 夥伴關係、聯盟、合資企業
  • 新產品發布和認證
  • 擴大生產能力和投資
  • 其他策略舉措

第14章：公司簡介

  • Amcor plc
  • Gerresheimer AG
  • Schott AG
  • West Pharmaceutical Services, Inc.
  • Becton, Dickinson and Company（BD）
  • AptarGroup, Inc.
  • Berry Global Group, Inc.
  • SGD Pharma
  • Owens-Illinois, Inc.
  • Nipro Corporation
  • Datwyler Holding Inc.
  • Catalent, Inc.
  • CCL Industries Inc.
  • Huhtamaki Oyj
  • Korber Pharma Packaging AG
Product Code: SMRC35503

According to Stratistics MRC, the Global Pharmaceutical Packaging Market is accounted for $170.3 billion in 2026 and is expected to reach $283.9 billion by 2034 growing at a CAGR of 6.6% during the forecast period. Pharmaceutical packaging encompasses primary, secondary, and tertiary solutions designed to protect, contain, and deliver drug products safely to end-users. It includes bottles, blister packs, vials, pre-filled syringes, cartons, and corrugated boxes. Built to ensure product integrity, extend shelf life, and comply with stringent safety regulations, pharmaceutical packaging enables manufacturers to maintain drug efficacy and patient safety. The market is evolving rapidly with smart technologies, anti-counterfeit features, and sustainable materials, thereby contributing significantly to improved healthcare logistics and medication adherence worldwide.

Market Dynamics:

Driver:

Growing demand for biologics and injectable drugs

The rising prevalence of chronic diseases such as diabetes, cancer, and autoimmune disorders is driving the development of biologic drugs and injectable therapies. These temperature-sensitive and complex molecules require advanced primary packaging solutions like pre-filled syringes, vials, and cartridges that ensure sterility and stability. Pharmaceutical manufacturers are increasingly investing in high-barrier packaging to protect biologics from moisture, light, and contamination. The shift toward self-administration and home healthcare further boosts demand for user-friendly, ready-to-use injectable packaging. As biologic pipelines expand globally, packaging innovation becomes critical to maintain drug efficacy and patient compliance, thereby accelerating market growth for specialized containment systems.

Restraint:

Fluctuating raw material costs and supply chain volatility

Pharmaceutical packaging heavily relies on plastics, glass, aluminum, and paperboard, all subject to price volatility due to geopolitical tensions, energy costs, and trade policies. Sudden increases in raw material prices compress profit margins for packaging manufacturers and force contract renegotiations with pharma companies. Additionally, supply chain disruptions-such as those experienced during global crises-delay the availability of essential components like rubber stoppers, caps, and specialty films. Smaller packaging converters struggle to secure consistent quality materials, leading to production bottlenecks. These fluctuations create uncertainty in long-term pricing agreements and challenge just-in-time inventory models, ultimately restraining market stability and growth potential.

Opportunity:

Adoption of smart and intelligent packaging technologies

The integration of near-field communication (NFC), radio-frequency identification (RFID), and QR codes into pharmaceutical packaging is revolutionizing drug safety and patient engagement. Smart packaging enables real-time temperature monitoring, tamper evidence, and counterfeit protection while allowing patients to access digital leaflet information and adherence reminders. Regulatory bodies are increasingly supporting serialization and track-and-trace mandates, creating a favorable environment for smart packaging adoption. Emerging markets are witnessing rapid deployment of authentication technologies to combat fake drugs. Innovations in printed electronics and low-cost sensors make intelligent packaging affordable for mass-market drugs. This trend opens new revenue streams for converters and technology providers.

Threat:

Stringent environmental regulations on plastic waste

Governments worldwide are imposing strict regulations on single-use plastics and non-recyclable packaging materials, directly impacting traditional pharmaceutical blister packs, bottles, and plastic films. Extended Producer Responsibility (EPR) laws require manufacturers to manage end-of-life disposal, increasing operational costs. Healthcare facilities and pharmacies face growing pressure to reduce plastic waste from drug packaging. Although bioplastics and recyclable alternatives exist, they often lack the barrier properties required for moisture-sensitive or sterile drugs. Transitioning to sustainable materials without compromising product safety requires significant R&D investment and requalification timelines. Non-compliance risks fines and reputational damage, threatening established packaging lines.

Covid-19 Impact

The pandemic dramatically accelerated pharmaceutical packaging demand, particularly for vaccines, diagnostics, and essential medications. Lockdowns initially disrupted raw material supply chains and glass vial production, leading to shortages. However, packaging manufacturers rapidly scaled up production of vials, pre-filled syringes, and cold-chain compliant shippers. The crisis spurred innovation in temperature-controlled tertiary packaging and aseptic filling lines. Regulatory agencies granted emergency approvals for alternative materials and suppliers. Post-pandemic, the industry has prioritized supply chain diversification, digital serialization, and resilient packaging networks. Investments in automation and near-shoring have increased to prevent future disruptions.

The primary packaging segment is expected to be the largest during the forecast period

The primary packaging segment is expected to account for the largest market share during the forecast period, driven by direct contact with drug products and stringent safety requirements. Bottles, blister packs, vials, ampoules, pre-filled syringes, and cartridges are essential for maintaining sterility, stability, and dosage accuracy. Technological advancements such as high-barrier films and child-resistant closures are enhancing patient safety. Rising biologic and injectable drug volumes are fueling demand for vials and pre-filled syringes.

The smart & intelligent packaging segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the smart and intelligent packaging segment is predicted to witness the highest growth rate, driven by increasing counterfeit drug incidents and regulatory serialization mandates. Integration of RFID, NFC, and temperature sensors enables real-time tracking, tamper evidence, and patient engagement through digital inserts. Pharmaceutical companies are adopting connected packaging to improve supply chain visibility and medication adherence. This segment is becoming pivotal in ensuring drug authenticity and patient safety across developed and emerging economies.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, driven by advanced pharmaceutical manufacturing, high biologic drug consumption, and stringent serialization mandates. The United States leads with major packaging innovators and strong demand for pre-filled syringes and smart packaging. Robust healthcare expenditure and early adoption of anti-counterfeit technologies further support market dominance. Established supply chains and regulatory clarity enable faster commercialization of advanced primary and intelligent packaging solutions across the region.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, fuelled by expanding pharmaceutical production in China, India, and Southeast Asia. Increasing generic drug exports, contract packaging activities, and government initiatives promoting local manufacturing drive demand. Rapid healthcare infrastructure modernization and rising chronic disease prevalence boost primary packaging consumption. Cost advantages, technology transfers from global players, and growing adoption of serialization and smart packaging solutions accelerate regional market growth significantly.

Key players in the market

Some of the key players in Pharmaceutical Packaging Market include Amcor plc, Gerresheimer AG, Schott AG, West Pharmaceutical Services, Inc., Becton, Dickinson and Company (BD), AptarGroup, Inc., Berry Global Group, Inc., SGD Pharma, Owens-Illinois, Inc., Nipro Corporation, Datwyler Holding Inc., Catalent, Inc., CCL Industries Inc., Huhtamaki Oyj, and Korber Pharma Packaging AG.

Key Developments:

In September 2025, Amcor plc launched a new line of recyclable high-barrier blister packaging for moisture-sensitive oral solid doses, designed to replace conventional PVC/PVDC laminates. The product received endorsement from the Association of Plastic Recyclers, supporting pharmaceutical companies' sustainability goals.

In June 2025, Gerresheimer AG announced the expansion of its pre-filled syringe manufacturing facility in Skopje, North Macedonia, to meet growing global demand for biologic drug delivery systems. The expansion includes advanced sterile filling lines and integrated inspection systems.

Product Types Covered:

  • Primary Packaging
  • Secondary Packaging
  • Tertiary Packaging

Materials Covered:

  • Plastics & Polymers
  • Glass
  • Paper & Paperboard
  • Aluminum Foil
  • Bioplastics & Sustainable Materials
  • Other Materials

Dosage Forms Covered:

  • Tablets & Capsules
  • Liquids & Syrups
  • Injectable
  • Powders & Granules
  • Creams & Ointments
  • Aerosols & Sprays
  • Transdermal Patches

Distribution Channels Covered:

  • Direct Sales
  • Distributors & Wholesalers
  • E-Commerce & Digital Platforms

Technologies Covered:

  • Blister Packaging
  • Strip Packaging
  • Bottle Filling & Capping
  • Sterile Packaging
  • Aseptic Packaging
  • Smart & Intelligent Packaging
  • Anti-Counterfeit Packaging
  • Child-Resistant & Senior-Friendly Packaging

End Users Covered:

  • Pharmaceutical & Biopharmaceutical Manufacturers
  • Contract Manufacturing Organizations (CMOs)
  • Contract Packaging Organizations (CPOs)
  • Retail & Hospital Pharmacies
  • Clinical Research Laboratories

Regions Covered:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
    • Netherlands
    • Belgium
    • Sweden
    • Switzerland
    • Poland
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Singapore
    • Vietnam
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Chile
    • Peru
    • Rest of South America
  • Rest of the World (RoW)
    • Middle East
  • Saudi Arabia
  • United Arab Emirates
  • Qatar
  • Israel
  • Rest of Middle East
    • Africa
  • South Africa
  • Egypt
  • Morocco
  • Rest of Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

  • 1.1 Market Snapshot and Key Highlights
  • 1.2 Growth Drivers, Challenges, and Opportunities
  • 1.3 Competitive Landscape Overview
  • 1.4 Strategic Insights and Recommendations

2 Research Framework

  • 2.1 Study Objectives and Scope
  • 2.2 Stakeholder Analysis
  • 2.3 Research Assumptions and Limitations
  • 2.4 Research Methodology
    • 2.4.1 Data Collection (Primary and Secondary)
    • 2.4.2 Data Modeling and Estimation Techniques
    • 2.4.3 Data Validation and Triangulation
    • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

  • 3.1 Market Definition and Structure
  • 3.2 Key Market Drivers
  • 3.3 Market Restraints and Challenges
  • 3.4 Growth Opportunities and Investment Hotspots
  • 3.5 Industry Threats and Risk Assessment
  • 3.6 Technology and Innovation Landscape
  • 3.7 Emerging and High-Growth Markets
  • 3.8 Regulatory and Policy Environment
  • 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

  • 4.1 Porter's Five Forces Analysis
    • 4.1.1 Supplier Bargaining Power
    • 4.1.2 Buyer Bargaining Power
    • 4.1.3 Threat of Substitutes
    • 4.1.4 Threat of New Entrants
    • 4.1.5 Competitive Rivalry
  • 4.2 Market Share Analysis of Key Players
  • 4.3 Product Benchmarking and Performance Comparison

5 Global Pharmaceutical Packaging Market, By Product Type

  • 5.1 Primary Packaging
    • 5.1.1 Bottles
    • 5.1.2 Blister Packs
    • 5.1.3 Vials & Ampoules
    • 5.1.4 Pre-Filled Syringes
    • 5.1.5 Cartridges
    • 5.1.6 Sachets & Strip Packs
  • 5.2 Secondary Packaging
    • 5.2.1 Cartons & Boxes
    • 5.2.2 Labels & Inserts
    • 5.2.3 Display Boxes
  • 5.3 Tertiary Packaging
    • 5.3.1 Corrugated Boxes
    • 5.3.2 Pallets & Shrink Wraps
    • 5.3.3 Drums & Bulk Containers

6 Global Pharmaceutical Packaging Market, By Material

  • 6.1 Plastics & Polymers
  • 6.2 Glass
  • 6.3 Paper & Paperboard
  • 6.4 Aluminum Foil
  • 6.5 Bioplastics & Sustainable Materials
  • 6.6 Other Materials

7 Global Pharmaceutical Packaging Market, By Dosage Form

  • 7.1 Tablets & Capsules
  • 7.2 Liquids & Syrups
  • 7.3 Injectable
  • 7.4 Powders & Granules
  • 7.5 Creams & Ointments
  • 7.6 Aerosols & Sprays
  • 7.7 Transdermal Patches

8 Global Pharmaceutical Packaging Market, By Distribution Channel

  • 8.1 Direct Sales
  • 8.2 Distributors & Wholesalers
  • 8.3 E-Commerce & Digital Platforms

9 Global Pharmaceutical Packaging Market, By Technology

  • 9.1 Blister Packaging
  • 9.2 Strip Packaging
  • 9.3 Bottle Filling & Capping
  • 9.4 Sterile Packaging
  • 9.5 Aseptic Packaging
  • 9.6 Smart & Intelligent Packaging
  • 9.7 Anti-Counterfeit Packaging
  • 9.8 Child-Resistant & Senior-Friendly Packaging

10 Global Pharmaceutical Packaging Market, By End User

  • 10.1 Pharmaceutical & Biopharmaceutical Manufacturers
  • 10.2 Contract Manufacturing Organizations (CMOs)
  • 10.3 Contract Packaging Organizations (CPOs)
  • 10.4 Retail & Hospital Pharmacies
  • 10.5 Clinical Research Laboratories

11 Global Pharmaceutical Packaging Market, By Geography

  • 11.1 North America
    • 11.1.1 United States
    • 11.1.2 Canada
    • 11.1.3 Mexico
  • 11.2 Europe
    • 11.2.1 United Kingdom
    • 11.2.2 Germany
    • 11.2.3 France
    • 11.2.4 Italy
    • 11.2.5 Spain
    • 11.2.6 Netherlands
    • 11.2.7 Belgium
    • 11.2.8 Sweden
    • 11.2.9 Switzerland
    • 11.2.10 Poland
    • 11.2.11 Rest of Europe
  • 11.3 Asia Pacific
    • 11.3.1 China
    • 11.3.2 Japan
    • 11.3.3 India
    • 11.3.4 South Korea
    • 11.3.5 Australia
    • 11.3.6 Indonesia
    • 11.3.7 Thailand
    • 11.3.8 Malaysia
    • 11.3.9 Singapore
    • 11.3.10 Vietnam
    • 11.3.11 Rest of Asia Pacific
  • 11.4 South America
    • 11.4.1 Brazil
    • 11.4.2 Argentina
    • 11.4.3 Colombia
    • 11.4.4 Chile
    • 11.4.5 Peru
    • 11.4.6 Rest of South America
  • 11.5 Rest of the World (RoW)
    • 11.5.1 Middle East
      • 11.5.1.1 Saudi Arabia
      • 11.5.1.2 United Arab Emirates
      • 11.5.1.3 Qatar
      • 11.5.1.4 Israel
      • 11.5.1.5 Rest of Middle East
    • 11.5.2 Africa
      • 11.5.2.1 South Africa
      • 11.5.2.2 Egypt
      • 11.5.2.3 Morocco
      • 11.5.2.4 Rest of Africa

12 Strategic Market Intelligence

  • 12.1 Industry Value Network and Supply Chain Assessment
  • 12.2 White-Space and Opportunity Mapping
  • 12.3 Product Evolution and Market Life Cycle Analysis
  • 12.4 Channel, Distributor, and Go-to-Market Assessment

13 Industry Developments and Strategic Initiatives

  • 13.1 Mergers and Acquisitions
  • 13.2 Partnerships, Alliances, and Joint Ventures
  • 13.3 New Product Launches and Certifications
  • 13.4 Capacity Expansion and Investments
  • 13.5 Other Strategic Initiatives

14 Company Profiles

  • 14.1 Amcor plc
  • 14.2 Gerresheimer AG
  • 14.3 Schott AG
  • 14.4 West Pharmaceutical Services, Inc.
  • 14.5 Becton, Dickinson and Company (BD)
  • 14.6 AptarGroup, Inc.
  • 14.7 Berry Global Group, Inc.
  • 14.8 SGD Pharma
  • 14.9 Owens-Illinois, Inc.
  • 14.10 Nipro Corporation
  • 14.11 Datwyler Holding Inc.
  • 14.12 Catalent, Inc.
  • 14.13 CCL Industries Inc.
  • 14.14 Huhtamaki Oyj
  • 14.15 Korber Pharma Packaging AG

List of Tables

  • Table 1 Global Pharmaceutical Packaging Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global Pharmaceutical Packaging Market Outlook, By Product Type (2023-2034) ($MN)
  • Table 3 Global Pharmaceutical Packaging Market Outlook, By Primary Packaging (2023-2034) ($MN)
  • Table 4 Global Pharmaceutical Packaging Market Outlook, By Bottles (2023-2034) ($MN)
  • Table 5 Global Pharmaceutical Packaging Market Outlook, By Blister Packs (2023-2034) ($MN)
  • Table 6 Global Pharmaceutical Packaging Market Outlook, By Vials & Ampoules (2023-2034) ($MN)
  • Table 7 Global Pharmaceutical Packaging Market Outlook, By Pre-Filled Syringes (2023-2034) ($MN)
  • Table 8 Global Pharmaceutical Packaging Market Outlook, By Cartridges (2023-2034) ($MN)
  • Table 9 Global Pharmaceutical Packaging Market Outlook, By Sachets & Strip Packs (2023-2034) ($MN)
  • Table 10 Global Pharmaceutical Packaging Market Outlook, By Secondary Packaging (2023-2034) ($MN)
  • Table 11 Global Pharmaceutical Packaging Market Outlook, By Cartons & Boxes (2023-2034) ($MN)
  • Table 12 Global Pharmaceutical Packaging Market Outlook, By Labels & Inserts (2023-2034) ($MN)
  • Table 13 Global Pharmaceutical Packaging Market Outlook, By Display Boxes (2023-2034) ($MN)
  • Table 14 Global Pharmaceutical Packaging Market Outlook, By Tertiary Packaging (2023-2034) ($MN)
  • Table 15 Global Pharmaceutical Packaging Market Outlook, By Corrugated Boxes (2023-2034) ($MN)
  • Table 16 Global Pharmaceutical Packaging Market Outlook, By Pallets & Shrink Wraps (2023-2034) ($MN)
  • Table 17 Global Pharmaceutical Packaging Market Outlook, By Drums & Bulk Containers (2023-2034) ($MN)
  • Table 18 Global Pharmaceutical Packaging Market Outlook, By Material (2023-2034) ($MN)
  • Table 19 Global Pharmaceutical Packaging Market Outlook, By Plastics & Polymers (2023-2034) ($MN)
  • Table 20 Global Pharmaceutical Packaging Market Outlook, By Glass (2023-2034) ($MN)
  • Table 21 Global Pharmaceutical Packaging Market Outlook, By Paper & Paperboard (2023-2034) ($MN)
  • Table 22 Global Pharmaceutical Packaging Market Outlook, By Aluminum Foil (2023-2034) ($MN)
  • Table 23 Global Pharmaceutical Packaging Market Outlook, By Bioplastics & Sustainable Materials (2023-2034) ($MN)
  • Table 24 Global Pharmaceutical Packaging Market Outlook, By Other Materials (2023-2034) ($MN)
  • Table 25 Global Pharmaceutical Packaging Market Outlook, By Dosage Form (2023-2034) ($MN)
  • Table 26 Global Pharmaceutical Packaging Market Outlook, By Tablets & Capsules (2023-2034) ($MN)
  • Table 27 Global Pharmaceutical Packaging Market Outlook, By Liquids & Syrups (2023-2034) ($MN)
  • Table 28 Global Pharmaceutical Packaging Market Outlook, By Injectable (2023-2034) ($MN)
  • Table 29 Global Pharmaceutical Packaging Market Outlook, By Powders & Granules (2023-2034) ($MN)
  • Table 30 Global Pharmaceutical Packaging Market Outlook, By Creams & Ointments (2023-2034) ($MN)
  • Table 31 Global Pharmaceutical Packaging Market Outlook, By Aerosols & Sprays (2023-2034) ($MN)
  • Table 32 Global Pharmaceutical Packaging Market Outlook, By Transdermal Patches (2023-2034) ($MN)
  • Table 33 Global Pharmaceutical Packaging Market Outlook, By Distribution Channel (2023-2034) ($MN)
  • Table 34 Global Pharmaceutical Packaging Market Outlook, By Direct Sales (2023-2034) ($MN)
  • Table 35 Global Pharmaceutical Packaging Market Outlook, By Distributors & Wholesalers (2023-2034) ($MN)
  • Table 36 Global Pharmaceutical Packaging Market Outlook, By E-Commerce & Digital Platforms (2023-2034) ($MN)
  • Table 37 Global Pharmaceutical Packaging Market Outlook, By Technology (2023-2034) ($MN)
  • Table 38 Global Pharmaceutical Packaging Market Outlook, By Blister Packaging (2023-2034) ($MN)
  • Table 39 Global Pharmaceutical Packaging Market Outlook, By Strip Packaging (2023-2034) ($MN)
  • Table 40 Global Pharmaceutical Packaging Market Outlook, By Bottle Filling & Capping (2023-2034) ($MN)
  • Table 41 Global Pharmaceutical Packaging Market Outlook, By Sterile Packaging (2023-2034) ($MN)
  • Table 42 Global Pharmaceutical Packaging Market Outlook, By Aseptic Packaging (2023-2034) ($MN)
  • Table 43 Global Pharmaceutical Packaging Market Outlook, By Smart & Intelligent Packaging (2023-2034) ($MN)
  • Table 44 Global Pharmaceutical Packaging Market Outlook, By Anti-Counterfeit Packaging (2023-2034) ($MN)
  • Table 45 Global Pharmaceutical Packaging Market Outlook, By Child-Resistant & Senior-Friendly Packaging (2023-2034) ($MN)
  • Table 46 Global Pharmaceutical Packaging Market Outlook, By End User (2023-2034) ($MN)
  • Table 47 Global Pharmaceutical Packaging Market Outlook, By Pharmaceutical & Biopharmaceutical Manufacturers (2023-2034) ($MN)
  • Table 48 Global Pharmaceutical Packaging Market Outlook, By Contract Manufacturing Organizations (CMOs) (2023-2034) ($MN)
  • Table 49 Global Pharmaceutical Packaging Market Outlook, By Contract Packaging Organizations (CPOs) (2023-2034) ($MN)
  • Table 50 Global Pharmaceutical Packaging Market Outlook, By Retail & Hospital Pharmacies (2023-2034) ($MN)
  • Table 51 Global Pharmaceutical Packaging Market Outlook, By Clinical Research Laboratories (2023-2034) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) are also represented in the same manner as above.